Skip to main content
ISPC
NASDAQ Industrial Applications And Services

iSpecimen to Acquire AI Assets from Foldlab for $4.5M in Cash and Stock

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$1.75
Mkt Cap
$3.879M
52W Low
$1.4
52W High
$127.2
52W Position info
25% above low
Off High info
99% below high
Rel. Volume info
4.9× avg
Market data snapshot near publication time

ISPC sits 25% above its 52-week low of $1.4 on elevated volume (4.9× avg).

Summary

iSpecimen agreed to acquire AI disease-research software from Foldlab AI for $4.5M, paying $2M cash and $2.5M in escrowed stock with a 5-year lock-up.


Key Events · M&A and Partnerships · ISPC

  • AI Asset Acquisition Agreement

    iSpecimen entered into an Asset Purchase Agreement with Foldlab AI Ltd. to acquire AI software, models, source code, and IP, including the Disease-Associated Protein Discovery AI Agent and Disease Trend Prediction AI Model.

  • $4.5M Purchase Price Structure

    Total consideration is $4.5M: $2M cash ($750K at closing plus two $625K milestone payments) and $2.5M in common stock priced at the 10-day VWAP before closing.

  • 5-Year Escrow and Lock-Up

    The $2.5M stock consideration is subject to a five-year escrow with no leak-out, no hedging, and no transfer, plus a voting rights agreement granting iSpecimen an irrevocable proxy.

  • Milestone Payments Contingent on Acceptance

    The $1.25M in milestone payments is payable only after successful delivery, testing, and acceptance of each AI product against objective criteria; no payment for partial performance or failed tests.


Analysis · ISPC · Industrial Applications And Services

iSpecimen is acquiring AI software and models from Foldlab AI Ltd. for $4.5 million — $2 million in cash and $2.5 million in stock. The stock portion is locked up for five years with no leak-out, and the cash includes $1.25 million in milestone payments only payable if the AI products pass objective acceptance tests. This is a strategic pivot into AI-driven disease research tools for a company with a going-concern warning and a market cap under $4 million. The deal requires stockholder approval, which adds execution risk.

How filings like this one have moved

In the 30 days to Sep 10, 2026, 30.1% of the 2014 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.11%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ISPC was trading at $1.75 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $3.9M. The 52-week trading range was $1.40 to $127.20. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ISPC - Latest Insights

ISPC
Sep 04, 2026, 5:20 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $1.86
Real-time Price: $1.50 info
Change: -$0.355 (-19%) info
Market Cap: $3.904M info
ISPC
Aug 31, 2026, 5:22 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.54
Real-time Price: $1.50 info
Change: -$0.040 (-3%) info
Market Cap: $3.904M info
ISPC
Aug 07, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.21
Real-time Price: $1.50 info
Change: -$0.710 (-32%) info
Market Cap: $3.904M info
ISPC
Aug 06, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.81
Real-time Price: $1.50 info
Change: -$0.3115 (-17%) info
Market Cap: $3.904M info
ISPC
Jul 16, 2026, 8:45 PM EDT
Filing Type: S-1/A
Importance Score:
8
Price at Filing: $2.25
Real-time Price: $1.50 info
Change: -$0.750 (-33%) info
Market Cap: $3.904M info